These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18619425)

  • 1. The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-beta1-42.
    Søderman A; Thomsen MS; Hansen HH; Nielsen EØ; Jensen MS; West MJ; Mikkelsen JD
    Brain Res; 2008 Aug; 1227():240-7. PubMed ID: 18619425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-7 nicotinic acetylcholine receptor agonists selectively activate limbic regions of the rat forebrain: an effect similar to antipsychotics.
    Hansen HH; Timmermann DB; Peters D; Walters C; Damaj MI; Mikkelsen JD
    J Neurosci Res; 2007 Jun; 85(8):1810-8. PubMed ID: 17455307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat.
    Kristensen SE; Thomsen MS; Hansen HH; Timmermann DB; Hay-Schmidt A; Mikkelsen JD
    Neurosci Lett; 2007 May; 418(2):154-8. PubMed ID: 17379406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct neural pathways mediate α7 nicotinic acetylcholine receptor-dependent activation of the forebrain.
    Thomsen MS; Hay-Schmidt A; Hansen HH; Mikkelsen JD
    Cereb Cortex; 2010 Sep; 20(9):2092-102. PubMed ID: 20051354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of nicotinic α(7) acetylcholine receptor enhances long term potentation in wild type mice but not in APP(swe)/PS1ΔE9 mice.
    Söderman A; Mikkelsen JD; West MJ; Christensen DZ; Jensen MS
    Neurosci Lett; 2011 Jan; 487(3):325-9. PubMed ID: 20974225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones.
    Fodero LR; Mok SS; Losic D; Martin LL; Aguilar MI; Barrow CJ; Livett BG; Small DH
    J Neurochem; 2004 Mar; 88(5):1186-93. PubMed ID: 15009674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
    Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
    Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective alpha7 nicotinic acetylcholine receptor agonist A-582941 activates immediate early genes in limbic regions of the forebrain: Differential effects in the juvenile and adult rat.
    Thomsen MS; Mikkelsen JD; Timmermann DB; Peters D; Hay-Schmidt A; Martens H; Hansen HH
    Neuroscience; 2008 Jun; 154(2):741-53. PubMed ID: 18495359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release.
    Bortz DM; Mikkelsen JD; Bruno JP
    Neuroscience; 2013; 255():55-67. PubMed ID: 24095692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
    Biton B; Bergis OE; Galli F; Nedelec A; Lochead AW; Jegham S; Godet D; Lanneau C; Santamaria R; Chesney F; Léonardon J; Granger P; Debono MW; Bohme GA; Sgard F; Besnard F; Graham D; Coste A; Oblin A; Curet O; Vigé X; Voltz C; Rouquier L; Souilhac J; Santucci V; Gueudet C; Françon D; Steinberg R; Griebel G; Oury-Donat F; George P; Avenet P; Scatton B
    Neuropsychopharmacology; 2007 Jan; 32(1):1-16. PubMed ID: 17019409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q; Xie X; Emadi S; Sierks MR; Wu J
    Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroprotective effects of alpha7 neuronal acetylcholine receptor and its roles in the pathogenesis of Alzheimer's disease].
    Qi XL; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):51-5. PubMed ID: 18509986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.
    Inestrosa NC; Godoy JA; Vargas JY; Arrazola MS; Rios JA; Carvajal FJ; Serrano FG; Farias GG
    Neuromolecular Med; 2013 Sep; 15(3):549-69. PubMed ID: 23842742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α7 nicotinic receptor agonism mitigates phencyclidine-induced changes in synaptophysin and Arc gene expression in the mouse prefrontal cortex.
    Thomsen MS; Hansen HH; Mikkelsen JD
    Neurochem Int; 2010 Dec; 57(7):756-61. PubMed ID: 20817066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.
    Andreasen JT; Redrobe JP; Nielsen EØ
    Pharmacol Biochem Behav; 2012 Jan; 100(3):624-9. PubMed ID: 22108649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
    Liu Q; Huang Y; Xue F; Simard A; DeChon J; Li G; Zhang J; Lucero L; Wang M; Sierks M; Hu G; Chang Y; Lukas RJ; Wu J
    J Neurosci; 2009 Jan; 29(4):918-29. PubMed ID: 19176801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
    Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
    J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.